Studies have shown that the expression level of LCN2 is increased in some tumour tissues, such as invasive breast cancer,100 pancreatic cancer101 and endometrial cancer,101 compared to normal tissues, indicating that overexpression of LCN2 is associated with the progression of a variety of cancers and is associated with poor prognosis.102. This evidence concerns the gene LCN2 and endometrial cancer.